Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Assessment of Cardiotoxicity by Cardiac MRI Versus MUGA Scans in Breast Cancer Patients Receiving Trastuzumab: A Double-Blinded Prospective Observational Pilot Study

Next Previous
Trial Profile

Assessment of Cardiotoxicity by Cardiac MRI Versus MUGA Scans in Breast Cancer Patients Receiving Trastuzumab: A Double-Blinded Prospective Observational Pilot Study

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 08 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Trastuzumab (Primary)
  • Indications Advanced breast cancer; Carcinoma; Early breast cancer
  • Focus Adverse reactions; Biomarker

Most Recent Events

  • 01 Apr 2019 Results (n=40) assessing early diastolic strain rate measurements by cardiac MRI in early breast cancer patients treated with trastuzumab published in the International Journal of Cardiovascular Imaging
  • 19 May 2015 Planned End Date changed from 1 Feb 2017 to 1 Dec 2019 as per ClinicalTrials.gov record.
  • 19 May 2015 Planned primary completion date changed from 1 Feb 2015 to 1 Dec 2019 as per ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top